- Linfa Wang, CSIRO Australia and Duke-NUS
- Joana Azeredo, University of Minho
- Hualan Chen, Chinese Academy of Agricultural Sciences
- Blossom Damania, University of North Carolina at Chapel Hill
- Andrew Easton, University of Warwick
- Tom Geisbert, University of Texas Medical Branch
- Erna Geessien Kroon, Universidade Federal de Minas Gerais
- Johnson Mak, Deakin University
- Alan McLachlan, University of Illinois at Chicago
- Klaus Osterrieder, Freie Universität Berlin
- Shin-Ru Shih, Chang Gung University
- Xueping Zhou, Zhejiang University
Diverse clinical response to two strains of influenza virus in ferrets demonstrated that host immunity, not the virus strain, was the determinant in the outcome of influenza virus infection.
More than 20% of the medical staff at a hospital in China were found to be infected with human Borna disease virus, calling for infection monitoring and introduction of preventive measures.
The multifaceted protein BRCA1 was identified to act as a novel transcriptional cofactor for HIV-1 transcription, indicating BRCA1 pathway or enzymes as targets in antiretroviral therapy.
Hepatitis B serologic survey in Fiji during 2008-2009 demonstrated a significant reduction of HBV infection rates in children and adults since 1998, indicating the HB immunization program is very successful.
Host cell protein hnRNP was found to interact with dengue virus RNA and promote viral replication, indicating viral and host protein interactions are required for viral replication.
Wild-type Influenza virus was generated under Good Manufacturing Practice conditions and shown to induce a good infectivity profile in human volunteers, proving to be a potential clinical challenge model.
Agnoprotein from polyomavirus BK was identified to interact with host cell protein PCNA and inhibit DNA synthesis, playing a role in switching off viral DNA replication to allow viral assembly.
Dr Jean Rommelaere summarizes the antineoplastic properties of parvoviruses, and discusses the development of novel parvovirus-based anticancer strategies for clinical use.
Aims & scope
Virology Journal is an open access, peer reviewed journal that considers articles on all aspects of virology, including research on the viruses of animals, plants and microbes. The journal welcomes basic research as well as pre-clinical and clinical studies of novel diagnostic tools, vaccines and anti-viral therapies.
The Editorial policy of Virology Journal is to publish all research which is assessed by peer reviewers to be a coherent and sound addition to the scientific literature, and puts less emphasis on interest levels or perceived impact.
Professor Linfa Wang is a leading researcher in emerging infections, including the discovery of novel, potentially zoonotic, viruses in bats. He is Director of the Program in Emerging Infectious Diseases at Duke-NUS Graduate Medical School, Singapore, and an Office of the Chief Executive Science Leader at CSIRO Australian Animal Health Laboratory (AAHL).